Attached files

file filename
10-K - FORM 10-K - ImmunoCellular Therapeutics, Ltd.d10k.htm
EX-31.2 - CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER - ImmunoCellular Therapeutics, Ltd.dex312.htm
EX-31.1 - CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER - ImmunoCellular Therapeutics, Ltd.dex311.htm
EX-23.1 - CONSENT OF MARCUM LLP - ImmunoCellular Therapeutics, Ltd.dex231.htm
EX-32.1 - CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER - ImmunoCellular Therapeutics, Ltd.dex321.htm
EX-10.52 - CONSULTING AGREEMENT - ImmunoCellular Therapeutics, Ltd.dex1052.htm
EX-10.54 - CO-PLACEMENT AGENTS AGREEMENT - ImmunoCellular Therapeutics, Ltd.dex1054.htm
EX-10.48 - EXCLUSIVE SUBLICENSE AGREEMENT - ImmunoCellular Therapeutics, Ltd.dex1048.htm
EX-10.50 - PLACEMENT AGENT AGREEMENT - GILFORD - ImmunoCellular Therapeutics, Ltd.dex1050.htm
EX-10.53 - ADVISORY SERVICES AGREEMENT - ImmunoCellular Therapeutics, Ltd.dex1053.htm
EX-10.49 - SPONSORED RESEARCH AND VACCINE PRODUCTION AGREEMENT - ImmunoCellular Therapeutics, Ltd.dex1049.htm
EX-10.51 - PLACEMENT AGENT AGREEMENT - SCARSDALE - ImmunoCellular Therapeutics, Ltd.dex1051.htm
EX-32.2 - CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER - ImmunoCellular Therapeutics, Ltd.dex322.htm

Exhibit 23.2

Consent Of Independent Registered Public Accounting Firm

We consent to the incorporation by reference in the Registration Statements of ImmunoCellular Therapeutics, Ltd. on Form S-8 (File Nos. 333-171652, 333-155199, 333-151968 and 333-147278) of our report dated March 31, 2010 with respect to our audit of the financial statements of ImmunoCellular Therapeutics, Ltd. as of December 31, 2009 and for the years ended December 31, 2009 and 2008 and the period from February 25, 2004 (inception) to December 31, 2009, which report is included in this Annual Report on Form 10-K of ImmunoCellular Therapeutics, Ltd. for the year ended December 31, 2010.

/s/ Stonefield Josephson, Inc.

Los Angeles, California

March 31, 2011